Hospital News and Research

RSS

Renal Ventures Management publishes first cookbook of kidney friendly recipes for renal patients

In recognition of Kidney Health Awareness Month, Renal Ventures Management, LLC (RVM), a leading provider of dialysis services for patients suffering from chronic kidney failure, has published its first cookbook of kidney friendly recipes for it renal patients and their families.

25 Mar 2014

BIND Therapeutics reports revenue of $2.1 million for fourth quarter 2013

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today reported financial results for the fourth quarter and year-ended December 31, 2013.

25 Mar 2014

TriMed Technologies' EHR version 7.9 achieves 2014 Edition Complete Ambulatory EHR Certification

TriMed Technologies, a leading provider of physician based healthcare information solutions, announced that its EHR (Electronic Health Record) version 7.9, has received 2014 Edition Complete Ambulatory EHR Certification, which designates that the software is capable of supporting healthcare providers with Stage 1 and Stage 2 Meaningful Use measures required to qualify for funding under the American Recovery and Reinvestment Act (ARRA).

25 Mar 2014

Endogenous tissue growth: an interview with Laurent Grandidier, CEO, Xeltis

ETG or Endogenous Tissue Growth is a new therapeutic category in which surgeons use implants designed to allow the body to repair itself by spontaneously growing natural, healthy tissue from the inside without the use of stem cells or animal-derived products.

25 Mar 2014

Genable Technologies, Spark Therapeutics to advance novel therapy for rare form of retinitis pigmentosa

Spark Therapeutics and Genable Technologies announced today that they have entered into a collaboration agreement for Genable's lead therapeutic to treat rhodopsin-linked autosomal dominant retinitis pigmentosa (RHO adRP), GT038.

25 Mar 2014

Researchers discover novel population of neutrophils that exhibit enhanced microbial killing activity

Case Western Reserve University researchers have discovered a novel population of neutrophils, which are the body's infection control workhorses. These cells have an enhanced microbial killing ability and are thereby better able to control infection.

25 Mar 2014

tPA can improve chances of recovering from stroke

When the clock starts ticking after the onset of stroke symptoms, access to a neurologist is crucial. Quickly diagnosing a stroke allows for the administration of lifesaving tPA (tissue plasminogen activator) in patients who quality for this treatment.

25 Mar 2014

High-volume medical centers improve gynecologic cancer survival

Women with ovarian and other gynecologic cancers live significantly longer when they receive care at hospitals that treat a large number of patients with these conditions, according to research on more than 850,000 women.

25 Mar 2014

State highlights: Fla. employees' unequal premiums; abuse by Calif. doctor alleged

The Florida Cabinet, state agency managers and legislative staff are among 30,000 top-ranked state workers who will continue to pay ultra-low health insurance premiums in the coming year. In a reverse of the Robin Hood principle, the state charges lower-paid workers six times more than those who have the highest earnings pay. ... [B]oth the House and Senate this week released initial budgets that would keep premiums at the same rate (3/22).

25 Mar 2014

Researchers exploit plasmonic nanoparticles to kill tumour cells

If you put your hand over a switched-on torch in the dark, it appears to glow red. This is because long-wavelength red light beams penetrate human tissue more effectively than short-wavelength blue light.

25 Mar 2014

XBP1 gene plays pivotal role in the growth and progression of triple negative breast cancer

Scientists from Weill Cornell Medical College and Houston Methodist have found that a gene previously unassociated with breast cancer plays a pivotal role in the growth and progression of the triple negative form of the disease, a particularly deadly strain that often has few treatment options. Their research, published in this week's Nature, suggests that targeting the gene may be a new approach to treating the disease.

25 Mar 2014

Smokers find difficult to savor bitter taste of caffeine, says study

Smokers and those who have quit cannot fully appreciate the full flavor of a cup of coffee, because many cannot taste the bitterness of their regular caffeine kick. This is the finding of a study led by Nelly Jacob of the Piti--Salp-tri-re Hospital APHP in France, published in Springer's journal Chemosensory Perception.

25 Mar 2014

Not all doctors offer cancer gene testing to patients, study finds

Many cancer researchers believe that cutting-edge advances in genomics will pave the way for personalized or "precision" cancer medicine for all patients in the near future. A new study by researchers at Dana-Farber Cancer Institute, however, suggest that not all doctors are ready to embrace tests that look for hundreds of DNA changes in patients' tumor samples, while others plan to offer this type of cancer gene testing to most of their patients.

25 Mar 2014

Faster DNA sequencing techniques more likely to improve care for patients with breast cancer

Faster and cheaper DNA sequencing techniques will likely improve care for patients with breast cancer but also create challenges for clinicians as they counsel patients on their treatment options.

25 Mar 2014

More skin cancer awareness needed for minorities, says Henry Ford Hospital dermatologist

More awareness about skin cancer is needed for minorities because they believe they are at low risk of developing it, says Henry Ford Hospital dermatologist Diane Jackson-Richards, M.D.

25 Mar 2014

Nasal spray holds promise as potential alternative therapeutic approach for depression

A nasal spray that delivers a peptide to treat depression holds promise as a potential alternative therapeutic approach, research from the Centre for Addiction and Mental Health (CAMH) shows.

25 Mar 2014

Homeless people who have suffered TBI are more likely to visit Emergency Department

Homeless and vulnerably housed people who have suffered a traumatic brain injury at some point in their life are more likely to visit an Emergency Department, be arrested or incarcerated, or be victims of physical assault, new research has found.

24 Mar 2014

New method can identify cancer's visible precursors with 97% certainty

Pancreatic cancer is often detected at a late stage, which results in poor prognosis and limited treatment options. Researchers at The University od Gothenburg, Sweden, have now developed a method which identifies the cancer's visible precursors with 97% certainty. The method, which is expected to aid in the early discovery of the cancer as well as minimize the risk of unnecessary surgery, may be introduced in patient care within five years.

24 Mar 2014

Drugs fail to "wake up" dormant reservoirs of HIV inside immune system T cells

Scientists at Johns Hopkins report that compounds they hoped would "wake up" dormant reservoirs of HIV inside immune system T cells - a strategy designed to reverse latency and make the cells vulnerable to destruction - have failed to do so in laboratory tests of such white blood cells taken directly from patients infected with HIV.

24 Mar 2014

State highlights: Ark. court reverses $1.2B Medicaid drug judgment; Fla. officials overhauling child welfare agency

The Arkansas Supreme Court reversed a $1.2 billion judgment against Johnson & Johnson on Thursday, finding that the state attorney general erred by suing under a law that applied to health care facilities, not drug companies. The judgment, one of the largest in history for a state fraud case, was imposed in 2012 after a jury concluded that Johnson & Johnson had improperly marketed and concealed the risks of Risperdal, an antipsychotic drug (Thomas, 3/2).

24 Mar 2014

Hospital News and Research

Renal Ventures Management publishes first cookbook of kidney friendly recipes for renal patients

BIND Therapeutics reports revenue of $2.1 million for fourth quarter 2013

TriMed Technologies' EHR version 7.9 achieves 2014 Edition Complete Ambulatory EHR Certification

Endogenous tissue growth: an interview with Laurent Grandidier, CEO, Xeltis

Genable Technologies, Spark Therapeutics to advance novel therapy for rare form of retinitis pigmentosa

Researchers discover novel population of neutrophils that exhibit enhanced microbial killing activity

tPA can improve chances of recovering from stroke

High-volume medical centers improve gynecologic cancer survival

State highlights: Fla. employees' unequal premiums; abuse by Calif. doctor alleged

Researchers exploit plasmonic nanoparticles to kill tumour cells

XBP1 gene plays pivotal role in the growth and progression of triple negative breast cancer

Smokers find difficult to savor bitter taste of caffeine, says study

Not all doctors offer cancer gene testing to patients, study finds

Faster DNA sequencing techniques more likely to improve care for patients with breast cancer

More skin cancer awareness needed for minorities, says Henry Ford Hospital dermatologist

Nasal spray holds promise as potential alternative therapeutic approach for depression

Homeless people who have suffered TBI are more likely to visit Emergency Department

New method can identify cancer's visible precursors with 97% certainty

Drugs fail to "wake up" dormant reservoirs of HIV inside immune system T cells

State highlights: Ark. court reverses $1.2B Medicaid drug judgment; Fla. officials overhauling child welfare agency

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News